0000914190-16-000766.txt : 20160822 0000914190-16-000766.hdr.sgml : 20160822 20160822171400 ACCESSION NUMBER: 0000914190-16-000766 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20160818 FILED AS OF DATE: 20160822 DATE AS OF CHANGE: 20160822 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: BIO-TECHNE Corp CENTRAL INDEX KEY: 0000842023 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 411427402 STATE OF INCORPORATION: MN FISCAL YEAR END: 0630 BUSINESS ADDRESS: STREET 1: 614 MCKINLEY PL N E CITY: MINNEAPOLIS STATE: MN ZIP: 55413 BUSINESS PHONE: 6123798854 MAIL ADDRESS: STREET 1: 614 MCKINLEY PLACE NE CITY: MINNEAPOLIS STATE: MN ZIP: 55413 FORMER COMPANY: FORMER CONFORMED NAME: TECHNE CORP /MN/ DATE OF NAME CHANGE: 19920703 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Bazan J. Fernando CENTRAL INDEX KEY: 0001583204 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-17272 FILM NUMBER: 161845916 MAIL ADDRESS: STREET 1: 614 MCKINLEY PLACE N.E. CITY: MINNEAPOLIS STATE: MN ZIP: 55413 4 1 edgar.xml PRIMARY DOCUMENT X0306 4 2016-08-18 0000842023 BIO-TECHNE Corp TECH 0001583204 Bazan J. Fernando 614 MCKINLEY PLACE N.E. MINNEAPOLIS MN 55413 0 1 0 0 Chief Technical Officer Stock Option (Right to Buy) 76.02 2020-07-31 Common Stock 10000 10000 D Stock Option (Right to Buy) 76.02 2020-07-31 Common Stock 15000 15000 D Stock Option (Right to Buy) 94.35 2021-08-12 Common Stock 15000 15000 D Stock Option (Right to Buy) 108.49 2022-08-07 Common Stock 10000 10000 D Stock Options (Right to Buy) 108.49 2022-08-07 Common Stock 7500 7500 D Restricted Stock Units Common Stock 1200 1200 D Stock Option (Right to Buy) 106.59 2016-08-18 4 A 0 14476 0 A 2023-08-18 Common Stock 14476 14476 D Stock Option (Right to Buy) 106.59 2016-08-18 4 A 0 10857 0 A 2023-08-18 Common Stock 10857 10857 D Restricted Stock Units 2016-08-18 4 A 0 1759 0 A Common Stock 1759 1759 D Vests 3,333 shares on each of 8/1/14 and 8/1/15 and 3,334 shares on 8/1/16. Vests 3,750 shares on each of 8/1/14, 8/1/15, 8/1/16 and 8/1/17. Vests 3,750 shares on each of 8/12/15, 8/12/16, 8/12/17 and 8/12/18. Vests 2,500 shares on each of 8/7/16, 8/7/17, 8/7/18 and 8/7/19. Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock. Vests in full or in part on 8/7/18 if certain performance goals are achieved (or such later date as performance is certified by the Administrator). Vests 3,619 shares on each of 8/18/17, 8/18/18, 8/18/19 and 8/18/20. Vests in full or in part on 8/18/19 if certain performance goals are achieved (or such later date as performance is certified by the Administrator). /s/ Elizabeth M. Dunshee as Attorney-in-Fact for J. Fernando Bazan pursuant to Power of Attorney previously filed. 2016-08-22